Irving Institute for Clinical and Translational Research

Irving Institute for Clinical and Translational Research
Name	Irving Institute for Clinical and Translational Research
Established	2008
Parent	Columbia University Irving Medical Center
Affiliation	Columbia University
Director	Muredach P. Reilly, M.B., B.Ch.
Location	New York, New York, U.S.

Irving Institute for Clinical and Translational Research is a major biomedical research hub at Columbia University Irving Medical Center in New York City. Established with a flagship grant from the National Institutes of Health, it serves as the academic home for translational science, accelerating the process of turning laboratory discoveries into effective treatments for patients. The institute integrates resources across Columbia University and its partner networks to support investigators and improve community health outcomes.

History and establishment

The institute was founded in 2008 following Columbia University’s successful application for a Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS). This award, part of a national consortium initiated by the National Institutes of Health, provided the foundational support to create a centralized entity for translational research. The institute was named in recognition of a transformative gift from the Irving family, longstanding philanthropists supporting Columbia University Irving Medical Center. Its creation consolidated numerous existing research resources and programs under one administrative umbrella, enhancing collaboration across departments like the Vagelos College of Physicians and Surgeons and the Mailman School of Public Health.

Mission and objectives

The core mission is to eliminate barriers between basic science and clinical application, fostering an environment where research insights rapidly benefit human health. Key objectives include providing robust infrastructure and funding for early-stage translational projects, training the next generation of translational scientists through dedicated educational programs, and promoting health equity by engaging diverse communities in New York City. The institute aims to streamline the entire research continuum, from initial hypothesis to implementation in clinical practice and public health policy, ensuring innovations reach all patient populations.

Core functions and services

The institute operates several essential service cores designed to support investigators. These include biostatistics and study design consultation through its Biomedical Informatics service, regulatory and ethical guidance via its Institutional Review Board navigation team, and pilot funding mechanisms for novel projects. It provides access to advanced technologies in genomics and proteomics through partnerships with core facilities like the Columbia Genome Center. Additional critical services encompass clinical research support within the Columbia University Irving Medical Center hospital system, data management resources, and community engagement studios that connect researchers with local patient advocates.

Key programs and initiatives

Notable programs include the Translational Research Fellowship, which trains postdoctoral scholars in multidisciplinary research methods. The Pilot Award Program funds high-risk, high-reward projects across the translational spectrum, often in collaboration with the Herbert Irving Comprehensive Cancer Center. Signature initiatives focus on specific health challenges, such as the COVID-19 research response, which mobilized rapid clinical trials and epidemiological studies. The institute also leads the Columbia-Care Coordination Center, a major NIH-funded effort integrating social determinants into clinical care, and partners with the NewYork-Presbyterian Hospital on pragmatic clinical trials.

Organizational structure and leadership

The institute is an integral component of Columbia University Irving Medical Center and reports through the office of the Dean of the Faculties of Health Sciences and Medicine. It is led by a director, a position held since 2019 by physician-scientist Muredach P. Reilly. Governance involves an executive committee comprising senior faculty from across the university, including representatives from the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, and the Fu Foundation School of Engineering and Applied Science. The structure includes dedicated divisions for bioinformatics, clinical research resources, community engagement, and education, each overseen by associate directors.

Impact and notable achievements

The institute has significantly accelerated translational output at Columbia University, contributing to breakthroughs in areas like precision oncology, neurovascular disease, and health disparities research. Its support has been instrumental in developing novel therapies tested in multicenter trials through networks like the NIH StrokeNet. It played a critical role during the COVID-19 pandemic, facilitating rapid research on therapeutics and vaccines. The institute’s educational programs have trained hundreds of scholars, many of whom now lead independent research programs at institutions such as the Mayo Clinic and Stanford University. Its community-based participatory research models have been adopted by other Clinical and Translational Science Award hubs nationwide.

Category:Columbia University Category:Medical and health organizations based in New York City Category:Medical research institutes in the United States Category:2008 establishments in New York (state)